Abstracts

Filters

Clear Filters
All Days Sun, Sep 27 Mon, Sep 28 Tue, Sep 29 Wed, Sep 30

Tuesday, September 29

2:35 PM - 2:45 PM ET

306 - Early Prediction of Local Recurrence after SBRT in Non-Small Cell Lung Cancer Using CT-Based Imaging Biomarkers and Clinical Factors
Speaker: Singh, Apurva, PhD, MS - Northwestern University Feinberg School of Medicine, Chicago, IL
2:35 PM - 2:45 PM ET

337 - Augmenting Patient Safety Surveillance in Radiation Oncology with Large Language Model-Based Root Cause Analysis
Speaker: Wang, Yuntao, MS - Mayo Clinic Arizona, Phoenix, AZ
2:35 PM - 2:45 PM ET

LBA 06 - NRG-HN009 Randomized Phase II/III Trial of RT + Cisplatin Q3 Weeks vs RT + Cisplatin Weekly for Patients with Locoregionally Advanced SCCHN: p16-Negative Phase II Toxicity Results
Speaker: Harari, Paul, MD, FASTRO - University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin
2:35 PM - 2:45 PM ET

LBA 14 - Prospective Neurocognitive Outcomes in Patients with 5 to 50 Brain Metastases Treated with Stereotactic Radiosurgery (SRS): A Phase II Clinical Trial
Speaker: Tseng, Chia-Lin, MD - Sunnybrook Health Sciences Centre, Toronto, Ontario
2:45 PM - 2:55 PM ET

130 - Growth Trajectory following Vertebral Body-Sparing Proton Craniospinal Irradiation in Pediatric Patients
Speaker: Daniels, Kristin, BS - UC San Diego School of Medicine, La Jolla, CA
2:45 PM - 2:55 PM ET

283 - Multi-Institutional Study of Stereotactic Radiosurgery in Patients with =15 Brain Metastases
Speaker: Vaziri, Tina, MD - Johns Hopkins Hospital, Baltimore, MD
2:45 PM - 2:55 PM ET

289 - Impact of Photon-Counting CT on Organ Segmentation Quality
Speaker: Baum, Sebastian, MS - Siemens Healthineers, Erlangen, Bayern
2:45 PM - 2:55 PM ET

296 - A Randomized Phase II Study of Hypofractionated Stereotactic Radiotherapy With Concurrent 5-fluorouracil /Capecitabine With or Without Zoledronic Acid in Locally Advanced Pancreatic Ductal Adenocarcinoma
Speaker: Lin, Chi, MD, PhD, MS - University of Nebraska Medical Center, Omaha, NE
2:45 PM - 2:55 PM ET

301 - Targeting TREM2+ Macrophages Overcomes Radiotherapy Resistance
Speaker: Wei, Shuhua, PhD - Peking University Third Hospital, Beijing, Beijing
2:45 PM - 2:55 PM ET

307 - Quantifying Dose-Dependent Changes in Active Bone Marrow Using Multi-Energy CT and Fat Fraction MRI in Pelvic Radiotherapy
Speaker: Eckrich, Carolyn, MS, BS - University of Wisconsin, Madison, WI
2:45 PM - 2:55 PM ET

338 - Development and Validation of a Vendor-Neutral Backup and Recovery Software for Cyberattack Resiliency
Speaker: Liang, Danfu, PhD - Thomas Jefferson University, Philadelphia, PA
2:45 PM - 2:55 PM ET

LBA 07 - A Phase II Trial of Induction Paclitaxel Followed by Concurrent Paclitaxel and Radiation Therapy for Cutaneous Angiosarcoma
Speaker: Raju-Salicki, Silpa, MD - Washington University in St. Louis, St. Louis, MO